Dance Biopharm's Unattributed VC - IV Round

Dance Biopharm raised a round of funding on September 25, 2018. Investors include SternAegis Ventures.

Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide.…

Articles about Dance Biopharm's Unattributed VC - IV Round: